Christmas gift for the kids? #radonc

New in JMIR: Assessing # #Patient -Reported Outcomes in Routine #Cancer Clinical Care Using Electronic Administration and #Telehealth Technologies: Realist Synthesis of Potential Mechanisms for Improving Health Outcomes dlvr.it/SzR1CQ

Today at #thoracic23 we presented the results of the SUNSET trial of SABR for ultra-central tumors, led by Meredith Giuliani

SABR warriors down under. #radonc #RANZCR22

Paper available!
Dose-Escalated 2-Fraction Spine Stereotactic Body Radiation Therapy: 28 Gy Versus 24 Gy in 2 Daily Fractions redjournal.org/article/S0360-…
#ASTRO22 #ASTRO2022

Ralph Weichselbaum This is a phase I trial: jamanetwork.com/journals/jamao…

New #OpenAccess review | Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus-associated oropharyngeal cancer acsjournals.onlinelibrary.wiley.com/doi/full/10.33… Nancy Lee Memorial Sloan Kettering Radiation Oncology Memorial Sloan Kettering Cancer Center

Drs Jennie Roberts, Angela Allen and Tuan Ha are our convenors for the 2023 ASM. Our co-convenors introduced the theme for next year at the #RANZCR2022 Gala Dinner, which is BEYOND. We look forward to welcoming you to Brisbane from 19-22 October 2023.

#RANZCR2023

5-yr Outcomes Ph III KN042 trial, Pembro v Chemo in 1L PDL1≥1% NSCLC ⁦Journal of Clinical Oncology⁩:

- HR OS in PDL1>50% 0.66, 5yr OS 21.9%
- HR OS in PDL1 1-49% 0.88, 95%CI crosses 1, 5yr OS 11.9%
- 33pts re-challenged w pembro, 15.2% ORR

⁦OncoAlert⁩ #LCSM ascopubs.org/doi/full/10.12…

Today is Day 1 of Lung Cancer Awareness Month 2022 ( #LCAM22 ). Fact: Did you know that #LungCancer causes more deaths globally than colon, breast, & prostate cancers combined? #LCSM

The conveners singing A Whole New World to kick off the Gala dinner ‘To Infinity and Beyond’ 💫 ⭐️ #RANZCR2022

So should be considering either 60/15 or SABR as a new standard of care for early stage centrally located NSCLC?

Any thoughts Corinne Faivre-Finn 💙 Clive Peedell David Ball AO Shankar Siva Shalini Vinod Fiona McDonald Petra Jankowska @sjharrow Drew Moghanaki 🐕 #radonc #lcsm

SABR has an increasing role in the treatment of #NSCLC patients with oligometastatic disease
sciencedirect.com/science/articl…
Dr. David Palma Puneeth Iyengar 5/8

November is #lungcancer awarenessmonth . Did you know that #radiotherapy is an important modality in the Rx of #lungcancer but is often underutilized? Eric Hau Gerry Hanna Clinical Oncology onlinelibrary.wiley.com/doi/10.1111/re… 1/8

The abstract book for #RANZCR2022 is now online!

ow.ly/tL6h50LjNtQ

🚨New in @CAonline: Review of deintensification for HPV‐positive OPC #headandNeckCancer #hncsm . The future may lie in incorporating intra-tx response assessments to harness the powers of personalized medicine & integrate real-time surveillance. #hncsm
👉acsjournals.onlinelibrary.wiley.com/doi/10.3322/ca…

The effect of cochlear dose on hearing preservation after low dose stereotactic radiosurgery for vestibular schwannomas: a systematic review advancesradonc.org/article/S2452-…
A practical approach will be to aim for a mean cochlear dose ˂ 4-6 Gy without compromising tumour dose.

To Infinity and Beyond. Thank you to @GEHealthcare for sponsoring last night's Gala Dinner at the Adelaide Convention Centre. Thank you to Ms Julia Keraand, MR Leader for Australia/New Zealand, for joining us on stage last night. Thank you to everyone who attended.
#RANZCR2022

This voluntary, RANZCR approved ANZPROG survey uses 5 case studies to assess the current utilisation of advanced palliative RT techniques & technologies in Australia & New Zealand. Responses will be de-identified & reported in aggregate only.

ow.ly/7FRL50Lh54X

In good news, our radiologists at UCLA already know this. Do yours? #radonc radiologybusiness.com/topics/healthc…